Single-ingredient formulation
Pejrox™
Etoricoxib 60 mg / 90 mg / 120 mg
Film-coated tablet · 10 × 10 tablets
View details
Single-ingredient formulation
Daxria™ Capsules
Dexlansoprazole 30 mg / 60 mg
Daxria™ capsules contain dexlansoprazole in 30 mg and 60 mg strengths, in a delayed-release formulation. Marketed by Shreemed Pharmaceutical Pvt. Ltd., Azadpur, Delhi.
Prices and availability are confirmed only by written quotation. We do not sell medicines online.
About Daxria™
Daxria™ is the brand under which Shreemed Pharmaceutical Pvt. Ltd. markets dexlansoprazole capsules in 30 mg and 60 mg strengths. Dexlansoprazole is a proton pump inhibitor (PPI) and the R-enantiomer of lansoprazole.
The capsule is a delayed-release formulation, designed so that the active ingredient is released after the capsule passes through the stomach.
Shreemed Pharmaceutical supplies its medicines to licensed chemists, hospitals and clinics, and through its retail counter, in accordance with the Drugs and Cosmetics Act, 1940 and the rules made under it.
Content on this website is for general information and is not medical advice. Consult a qualified healthcare professional before using any medicine. Prescription medicines are supplied only as permitted by law.
Pejrox™, Codfax™, Cizmi-O™, Daxria™, Zamta™ and Zamta Plus™ are brands of Shreemed Pharmaceutical Pvt. Ltd.
